In this week's recap: New COVID‐19 infections drive market anxieties, despite
anticipated vaccines; Fed Chair Powell warns that continued infections may limit
In this week's recap: A COVID‐19 vaccine spurs a stock market rally, even as more cases are reported and some areas renew lockdowns.
In this week's recap: With no fiscal stimulus anticipated and election around the corner, stocks slumped through a difficult week.
Stocks treaded water last week amid fading prospects for a stimulus bill, fears of a second wave of COVID‐19 cases, and increasing political and regulatory
Stocks advanced last week, propelled by hopes that legislators may reach an agreement for a new
fiscal stimulus package and optimism generated by a few
Stocks were mixed last week as worries that stretched from Washington D.C., where prospects of a
new fiscal stimulus bill dimmed, to Europe, which saw an
Stocks slipped as the technology sector remained under pressure and a mid‐week announcement by
the Federal Reserve failed to inspire investors.
Stocks advanced relentlessly last week on positive COVID‐19 developments, encouraging economic data, and a supportive policy shift in the Fed's approach to its
Stocks powered to another week of gains as the S&P 500 and Nasdaq Composite set multiple new record highs along the way.
Stock prices drifted higher in an otherwise quiet news week, as a slowdown in new COVID‐19 cases
outweighed a Congressional impasse on a new fiscal spending
Stocks were mixed last week amid a busy week of earnings, some troubling economic data, and seemingly little progress on a new fiscal stimulus package.
Stocks slipped in the final days of trading last week on higher jobless claims and rising tensions in the U.S.‐China relationship.